Descrizione

Principal components analysis of bacterial phyla changes from baseline to week 8, comparing the curcumin and placebo groups' intestinal microbiota compositional shifts.

Figure 5

Chart

Source Paper

Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, …

BMC complementary medicine and therapies (2021)

PMID: 33478482

DOI: 10.1186/s12906-021-03220-6

Cite This Figure

![Figure 5: Principal components analysis of bacterial phyla changes from baseline to week 8, comparing the curcumin and placebo groups' intestinal microbiota compositional shifts.]()

> Source: Adrian L Lopresti et al. "Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and inte." *BMC complementary medicine and therapies*, 2021. PMID: [33478482](https://pubmed.ncbi.nlm.nih.gov/33478482/)

<figure>
  <img src="" alt="Principal components analysis of bacterial phyla changes from baseline to week 8, comparing the curcumin and placebo groups' intestinal microbiota compositional shifts." />
  <figcaption>Figure 5. Principal components analysis of bacterial phyla changes from baseline to week 8, comparing the curcumin and placebo groups' intestinal microbiota compositional shifts.<br>  Source: Adrian L Lopresti et al. "Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and inte." <em>BMC complementary medicine and therapies</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33478482/">33478482</a></figcaption>
</figure>

Evidenze correlate

Curcumin per Irritable Bowel Syndrome (IBS)

Grado C · 2 studi